Rate Video

VJVirtual | Cell-free DNA liquid biopsy in lung cancer

Geoffrey Oxnard • 9 Apr 2020

General Lung Cancer

Geoffrey Oxnard, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the use of liquid biopsy for identifying resistance mutations to guide therapy decisions. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Cell-free DNA sequencing in the clinical setting

Geoffrey Oxnard • 28 Sep 2019

The Pitfalls of cell-free DNA sequencing

Geoffrey Oxnard • 28 Sep 2019

Cancer detecting and locating: cell-free DNA

Geoffrey Oxnard • 28 Sep 2019

TATTON: Phase 1b trial of AZD9291 for EGFR-mutant lung cancer

Geoffrey Oxnard • 30 May 2015

Related Videos

Personalized dosing of pembrolizumab has the potential to save $0.8 billion per year

Daniel Goldstein

How molecular therapeutics have changed the role of radiology in lung cancer care

Gerhard Mostbeck

EBUS and CT-guided biopsy in repeat biopsies of patients with progressive lung cancer

Promising results from the CLINVO study for Non-Small Cell Lung Cancer patients